<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.themarketsdaily.com/2019/11/25/botanix-pharmaceuticals-asxbot-trading-4-8-higher.html"/>
    <meta property="og:site_name" content="Markets Daily"/>
    <meta property="article:published_time" content="2019-11-25T23:42:43+00:00"/>
    <meta property="og:title" content="Botanix Pharmaceuticals (ASX:BOT) Trading 4.8% Higher"/>
    <meta property="og:description" content="Botanix Pharmaceuticals Ltd (ASX:BOT)’s share price traded up 4.8% on Monday . The stock traded as high as A$0.11 ($0.08) and last traded at A$0.11 ($0.08), 742,500 shares changed hands during trading. A decline of 83% from the average session volume of 4,450,000 shares. The stock had previously closed at A$0.11 ($0.07). The company has […]"/>
  </head>
  <body>
    <article>
      <h1>Botanix Pharmaceuticals (ASX:BOT) Trading 4.8% Higher</h1>
      <address><time datetime="2019-11-25T23:42:43+00:00">25 Nov 2019, 23:42</time> by <a rel="author">Sarita Garza</a></address>
      <p>Botanix Pharmaceuticals Ltd (ASX:BOT)’s share price traded up 4.8% on Monday . The stock traded as high as A$0.11 ($0.08) and last traded at A$0.11 ($0.08), 742,500 shares changed hands during trading. A decline of 83% from the average session volume of 4,450,000 shares. The stock had previously closed at A$0.11 ($0.07).</p>
      <p>The company has a 50 day simple moving average of A$0.17 and a two-hundred day simple moving average of A$0.18. The firm has a market cap of $106.10 million and a PE ratio of -5.00.</p>
      <p><b>Botanix Pharmaceuticals Company Profile</b> (<a href="https://www.marketbeat.com/stocks/ASX/BOT/">ASX:BOT</a>)</p>
      <p>Botanix Pharmaceuticals Limited, a clinical stage medical dermatology company, develops therapeutics for the treatment of serious skin diseases in Australia. The company offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; and BTX 1701, a novel product for mild acne.</p>
      <p>Recommended Story: <a href="https://www.marketbeat.com/financial-terms/what-is-a-derivative/">What is a Derivative?</a></p>
    </article>
  </body>
</html>